Jurga Adomaityte, MD: From the division of general internal medicine/hospitalist program, The Johns Hopkins School of Medicine, Baltimore, MD.

We performed a systematic review and meta-analysis of all clinical trials comparing routine invasive strategy with selective invasive strategy in patients with non–ST-segment elevation acute coronary syndrome. We did not find either strategy to offer an advantage over the other, even when we excluded trials that did not use coronary stents and glycoprotein IIb/IIIa inhibitors.